Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder

Depression and Anxiety

Volumn 29, Issue 4, 2012, Pages 328-339

  Strawn, Jeffrey R ^a,b   Wehry, Anna M ^a   Delbello, Melissa P ^a,b   Rynn, Moira A ^c   Strakowski, Stephen ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

anterior limbic network; anxiety disorders; fMRI; GAD; SSRI; youth

Indexed keywords

ALPRAZOLAM; BUSPIRONE; FLUOXETINE; FLUVOXAMINE; SERTRALINE; VENLAFAXINE;

ABDOMINAL DISCOMFORT; ADOLESCENT; AGITATION; AMYGDALOID NUCLEUS; ANOREXIA; ANTERIOR CINGULATE; ASTHENIA; BRAIN MAPPING; CHILD; COGNITIVE THERAPY; CONFERENCE PAPER; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FATIGUE; FIDGETING; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; INSOMNIA; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NAUSEA; NEUROBIOLOGY; NEUROIMAGING; PAIN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RESTLESSNESS; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; AMYGDALA; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; CHILD; HUMANS; PREFRONTAL CORTEX; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 84860643761     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21913     Document Type: Conference Paper

References (74)

1. Beesdo K, Pine DS, Lieb R, Wittchen HU,. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67 (1): 47-57.
2. Beesdo K, Knappe S, Pine DS,. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin N Am 2009; 32: 483-524.
3. Birmaher B, Yelovich AK, Renaud J,. Pharmacologic treatment for children and adolescents with anxiety disorders. Pediatr Clin North Am 1998; 45: 1187-1204. (Pubitemid 28477692)
4. Pine DS, Cohen P, Gurley D, Brook J, Ma Y,. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55 (1): 56-64. (Pubitemid 28069040)
5. Foley DL, Goldston DB, Costello EJ, Angold A,. Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. Arch Gen Psychiatry 2006; 63 (9): 1017-24. (Pubitemid 44330461)
6. Jacobson CM, Muehlenkamp JJ, Miller AL, Turner JB,. Psychiatric impairment among adolescents engaging in different types of deliberate self-harm. J Clin Child Adolesc Psychol 2008; 37 (2): 363-75.
7. Costello EJ, Janiszewski S,: Who gets treated? Factors associated with referral in children with psychiatric disorders. Acta Psychiatr Scand 1990; 81: 523-29. (Pubitemid 20333527)
8. Chavira DA, Stein MB, Bailey K, Stein MT,. Child anxiety in primary care: prevalent but untreated. Depress Anxiety 2004; 20 (4): 155-64. (Pubitemid 40204452)
9. Strawn JR, Adler CM, Chu W, Eliasson JC, Whitsel R, Weber WA, Strakowski SM, DelBello MP,. Adolescent generalized anxiety disorder: neurophysiology and neurochemistry. Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP), New York, NY, October 26-31, 2010.
10. Britton JC,. Using neuroscience to generate novel anxiety disorder treatments. Fifty-Seventh Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP), New York, NY, 2010;43.2.
11. Yamasaki H, LaBar KS, McCarthy G,. Dissociable prefrontal brain systems for attention and emotion. Proc Natl Acad Sci USA 2002; 99: 11447-11451. (Pubitemid 34920945)
12. Moore RY, Halaris AE, Jones BE,. Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 1978; 180 (3): 417-38.
13. Azmitia EC, Gannon PJ,. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol 1986; 43: 407-468.
14. Zezula J, Cortés R, Probst A, Palacios JM,. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988; 25 (3): 771-95.
15. Rynn M, Puliafico A, Heleniak C, Rikhi P, Ghalib K, Vidair H,. Advances in pharmacotherapy for pediatric anxiety disorders. Depress Anxiety 2011; 28 (1): 76-87.
16. Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB,. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry 2005; 62 (3): 282-288. (Pubitemid 40990973)
17. Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD,. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry 2009; 66 (12): 1361-1372.
18. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF,. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry 2010; 167 (5): 545-554.
19. Cerullo MA, Adler CM, Delbello MP, Strakowski SM,. The functional neuroanatomy of bipolar disorder. Int Rev Psychiatry 2009; 21 (4): 314-322.
20. Strakowski SM, Eliassen JC, Lamy M, Cerullo MA, Allendorfer JB, Madore M, Lee JH, Welge JA, DelBello MP, Fleck DE, Adler CM,. Functional magnetic resonance imaging brain activation in bipolar mania: evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway. Biol Psychiatry 2011; 69 (4): 381-388.
21. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P,. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 2001; 935: 107-17. (Pubitemid 32511395)
22. De Bellis MD, Keshavan MS, Shifflett H, Iyengar S, Dahl RE, Axelson DA, Birmaher B, Hall J, Moritz G, Ryan ND,. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2002; 51 (7): 553-562. (Pubitemid 34327330)
23. Milham MP, Nugent AC, Drevets WC, Dickstein DP, Leibenluft E, Ernst M, Charney D, Pine DS,. Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation. Biol Psychiatry 2005; 57 (9): 961-966. (Pubitemid 40603078)
24. Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, Chen G, McClure-Tone EB, Ernst M, Pine DS,. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 2008; 65 (5): 568-576. (Pubitemid 351645052)
25. Monk CS, Nelson EE, McClure EB, Mogg K, Bradley BP, Leibenluft E, Blakir RJR, Chen G, Charney DS, Ernst M, Pine DS,. Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry 2006; 163: 1091-1097. (Pubitemid 44464497)
26. Blair K, Shaywitz J, Smith BW, Rhodes R, Geraci M, Jones M, McCaffrey D, Vythilingam M, Finger E, Mondillo K, Jacobs M, Charney DS, Blair RJ, Drevets WC, Pine DS,. Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders. Am J Psychiatry 2008; 165: 1193-1202.
27. Phillips ML, Ladouceur CD, Drevets WC,. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13 (9):829, 833-57.
28. Tian S, Huang F, Gao J, Li P, Ouyang X, Zhou S, Deng H, Yan Y,. Ventrolateral prefrontal cortex is required for fear extinction in a modified delay conditioning paradigm in rats. Neuroscience 2011 [Epub ahead of print].
29. Britton JC, Lissek S, Grillon C, Norcross MA, Pine DS,. Development of anxiety: the role of threat appraisal and fear learning. Depress Anxiety 2011; 28 (1): 5-17.
30. Maskowsky J, Mogg K, Bradley BP, McClure-Tone E, Ernst M, Pine DS, Monk CS,. 2010. A preliminary investigation of the neural correlates of treatment in adolescents with generalized anxiety disorder. J Child Adolesc Psychopharmacol 2010; 20 (2): 105-111.
31. Strawn JR, Bitter SM, Adler CA, Whitsel R, Weber W, Strakowski SM, DelBello MP,. Neurocircuitry of generalized anxiety disorder in adolescents: a Functional Connectivity Study. Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP), Toronto, Canada, 2011.
32. Devinsky O, Morrell MJ, Vogt BA,. Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118: 279-306.
33. Etkin A, Egner T, Kalisch R,. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 2011; 15 (2): 85-93.
34. Bush G, Vogt BA, Holmes J, Dale AM, Greve D, Jenike MA, Rosen BR,. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci USA 2002; 99 (1): 523-528. (Pubitemid 34060394)
35. Krain AL, Gotimer K, Hefton S, Ernst M, Castellanos FX, Pine DS, Milham MP,. A functional magnetic resonance imaging investigation of uncertainty in adolescents with anxiety disorders. Biol Psychiatry 2008 63 (6): 563-568. (Pubitemid 351273188)
36. Rynn MA, Siqueland L, Rikels K,. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001; 158: 2008-2014. (Pubitemid 33104106)
37. Hamilton M,. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32 (1): 50-5.42.
38. Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, Bridge J, Heo J, Brent DA,. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003; 42 (4): 415-423. (Pubitemid 39625076)
39. RUPP. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002; 41 (9): 1061-1069.
40. Rynn MA, Riddle MA, Yeung PP, Kunz N,. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007; 164 (2): 290-300.
41. RUPP. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001; 344 (17): 1279-1285.
42. Salazar DE, Frackiewicz EJ, Dockens R, Kollia G, Fulmor IE, Tigel PD, Uderman HD, Shiovitz TM, Sramek JJ, Cutler NR,. Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. J Clin Pharmacol 2001; 41 (12): 1351-1358. (Pubitemid 33104903)
43. Simeon JG, Ferguson HB, Knott V, Roberts N, Gauthier B, Dubois C, Wiggins D,. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 1992; 31 (1): 29-33.
44. Simeon JG, Ferguson HB,. Alprazolam effects in children with anxiety disorders. Can J Psychiatry 1987; 32 (7): 570-574. (Pubitemid 18051094)
45. Kendall PC,. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol 1994; 62 (1): 100-110. (Pubitemid 24058702)
46. Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, Southam-Gerow M, Henin A, Warman M,. Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol 1997; 65 (3): 366-380. (Pubitemid 27246778)
47. Barrett PM, Dadds MR, Rapee RM,. Family treatment of childhood anxiety: a controlled trial. J Consult Clin Psychol 1996 64 (2): 333-342. (Pubitemid 26131630)
48. James A, Soler A, Weatherall R,. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005; 19: CD004690.
49. Young JF, Mufson L, Davies M,. Impact of comorbid anxiety in an effectiveness study of interpersonal psychotherapy for depressed adolescents. J Am Acad Child Adolesc Psychiatry 2006; 45 (8): 904-912. (Pubitemid 44126864)
50. Albano AM,. Advances in psychotherapy for pediatric generalized anxiety disorder. 57th Annual Meeting of the American Academy of Child & Adolescent Psychiatry (AACAP). New York, NY. 2010; 43.4
51. Fonagy P, Target M,. Predictors of outcome in child psychoanalysis: a retrospective study of 763 cases at the Anna Freud Centre. J Am Psychoanal Assoc 1996; 44 (1): 27-77. (Pubitemid 26134155)
52. McClure EB, Adler A, Monk CS, Cameron J, Smith S, Nelson EE, Leibenluft E, Ernst M, Pine DS,. fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) 2007b; 191 (1): 97-105. (Pubitemid 46294944)
53. Del-Ben CM, Deakin JF, McKie S, Delvai NA, Williams SR, Elliott R, Dolan M, Anderson IM,. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 2005; 30 (9): 1724-1734. (Pubitemid 43090698)
54. Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP,. Escitalopram effects on insula and amygdala BOLDactivation during emotional processing. Psychopharmacology (Berl) 2008; 196 (4): 661-672.
55. Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S,. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage 2010; 49 (2): 1161-1170.
56. van Marle HJ, Tendolkar I, Urner M, Verkes RJ, Fernández G, van Wingen G,. Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals. Neuroimage 2011; 55 (2): 825-831.
57. Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ, Kalin NH,. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009; 166 (3): 302-310.
58. Whalen PJ, Johnstone T, Somerville LH, Nitschke JB, Polis S, Alexander AL, Davidson RJ, Kalin NH,. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry 2008; 63 (9): 858-863. (Pubitemid 351458450)
59. Arce E, Miller DA, Feinstein JS, Stein MB, Paulus MP,. Lorazepam dose-dependently decreases risk-taking related activation in limbic areas. Psychopharmacology (Berl) 2006 189 (1): 105-116 [Epub October 3, 2006]. (Pubitemid 44607264)
60. Del-Ben CM, Ferreira CA, Sanchez TA, Alves-Neto WC, Guapo VG, de Araujo DB, Graeff FG,. Effects of diazepam on BOLDactivation during the processing of aversive faces. J Psychopharmacol 2010 [Epub ahead of print].
61. Pine DS, Guyer AE, Leibenluft E,. Functional magnetic resonance imaging and pediatric anxiety. J Am Acad Child Adolesc Psychiatry 2008; 47 (11): 1217-1221.
62. Degnan KA, Almas AN, Fox NA,. Temperament and the environment in the etiology of childhood anxiety. J Child Psychol Psychiatry 2010; 51 (4): 497-517.
63. Waters AM, Henry J, Mogg K, Bradley BP, Pine DS,. Attentional bias towards angry faces in childhood anxiety disorders. J Behav Ther Exp Psychiatry 2010; 41 (2): 158-164.
64. Roberson-Nay R, McClure EB, Monk CS, Nelson EE, Guyer AE, Fromm SJ, Charney DS, Leibenluft E, Blair J, Ernst M, Pine DS,. Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: an fMRIstudy. Biol Psychiatry 2006; 60 (9): 966-973. (Pubitemid 44584205)
65. De Bellis MD, Casey BJ, Dahl RE, Birmaher B, Williamson DE, Thomas KM, Axelson DA, Frustaci K, Boring AM, Hall J, Ryan ND,. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2000; 48 (1): 51-57. (Pubitemid 30407149)
66. Cartwright-Hatton S,. Anxiety of childhood and adolescence: challenges and opportunities. Clin Psychol Rev 2006; 26 (7): 813-816. (Pubitemid 44466140)
67. Hankin BL, Gibb BE, Abela JR, Flory K,. Selective attention to affective stimuli and clinical depression among youths: role of anxiety and specificity of emotion. J Abnorm Psychol 2010; 119 (3): 491-501.
68. Keeton CP, Kolos AC, Walkup JT,. Pediatric generalized anxiety disorder: epidemiology, diagnosis and management. Pediatr Drugs 2009; 11 (3): 171-183.
69. Lee JH, Garwood M, Menon R, Adriany G, Anderson P, Truwit CL, Ugurbil K,. High contrast and fast three-deimensional magnetic resonance imaging at high fields. Magn Reson Med 1995; 34: 308-312.
70. McClure EB, Monk CS, Nelson EE, Parrish JM, Adler A, Blair RJ, Fromm S, Charney DS, Leibenluft E, Ernst M, Pine DS,. Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 2007a; 64 (1): 97-106. (Pubitemid 46041743)
71. Rainnie DG,. Serotonergic modulation of neurotransmission in the rat basolateral amygdala. Neurophysiol 1999; 82 (1): 69-85. (Pubitemid 29330062)
72. Schmithorst VJ, Dardzinski BJ, Holland SK,. Simultaneous correction of ghost and geometric distortion artifacts in EPIusing a multiecho reference scan. IEEE Trans Med Imaging 1995; 20: 535-539.
73. Stein MB,. Neurobiology of generalized anxiety disorder. J Clin Psychiatry 2009; 70 (2): 15-19.
74. Strawn JR,. Pediatric generalized anxiety disorder: developmental course and comorbidity. 57th Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP), New York, NY, 2010; 43.1.